Overview

Benznidazole Absorption, Metabolism and Excretion Study

Status:
Completed
Trial end date:
2018-09-02
Target enrollment:
Participant gender:
Summary
This Phase I ADME study will be conducted to evaluate the pharmacokinetics of benznidazole.
Phase:
Phase 1
Details
Lead Sponsor:
Exeltis France
Collaborator:
Insud Pharma
Treatments:
Benzonidazole